scispace - formally typeset
S

Shirin Ilkhanizadeh

Researcher at University of California, San Francisco

Publications -  13
Citations -  4725

Shirin Ilkhanizadeh is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Stem cell & Cancer stem cell. The author has an hindex of 8, co-authored 11 publications receiving 3723 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma

TL;DR: This study re-establishes mTOR as a central target in glioma and traces the failure of existing drugs to incomplete/nondurable inhibition of mTORC1 to RapaLink-1, a TORKi linked to rapamycin, with earlier-generation mTOR inhibitors.
Journal ArticleDOI

STAT3 blockade inhibits radiation-induced malignant progression in glioma

TL;DR: It is found that cranial ionizing radiation induced robust and durable PMT in tumors and clinical JAK2 inhibitors should be tested in conjunction with radiation in patients with proneural HGG as a new strategy for blocking the emergence of therapy-resistant mesenchymal tumors at relapse.
Journal ArticleDOI

Generating trunk neural crest from human pluripotent stem cells.

TL;DR: This approach provides methodology for detailed studies of human NCC, and clarifies roles for retinoids and BMPs in the differentiation of human PSC to trunk NCC and to sympathoadrenal lineages.
Journal ArticleDOI

Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis.

TL;DR: It is demonstrated that human NES cells provide a potent experimental resource for dissecting genetic causation in medulloblastoma, and candidate cooperating mutations in Gorlin NES cells are engineered to accelerate tumorigenesis.